ClinicalTrials.govpublic full text
Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib
metastatic renal cell carcinoma (mrcc), kidney cancer, mrcc, metastic renal cell carcinoma, everolimus, sunitinib, pazopanib, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829067
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.